Nektar Therapeutics Files SEC Form D, Notice of Exempt Offering of Securities: (Mar. 19, 2024)

MLA

“Nektar Therapeutics Files SEC Form D, Notice of Exempt Offering of Securities: (Mar. 19, 2024).” Obesity, Fitness & Wellness Week, Apr. 2024, p. 1737. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.788215718&authtype=sso&custid=ns315887.

APA

Nektar Therapeutics Files SEC Form D, Notice of Exempt Offering of Securities: (Mar. 19, 2024). (2024, April 6). Obesity, Fitness & Wellness Week, 1737.

Chicago

Obesity, Fitness & Wellness Week. 2024. “Nektar Therapeutics Files SEC Form D, Notice of Exempt Offering of Securities: (Mar. 19, 2024),” April 6. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.788215718&authtype=sso&custid=ns315887.